These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS, Aslam M, Naveed AK, Razi MS. Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671 [Abstract] [Full Text] [Related]
5. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. Jin HB, Gu ZY, Yu CH, Li YM. Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522 [Abstract] [Full Text] [Related]
7. HDL atheroprotection by aerobic exercise training in type 2 diabetes mellitus. Ribeiro IC, Iborra RT, Neves MQ, Lottenberg SA, Charf AM, Nunes VS, Negrão CE, Nakandakare ER, Quintão EC, Passarelli M. Med Sci Sports Exerc; 2008 May; 40(5):779-86. PubMed ID: 18408623 [Abstract] [Full Text] [Related]
8. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. Velussi M. Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227 [Abstract] [Full Text] [Related]
9. Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis. Afrasyap L, Oztürk G. Vascul Pharmacol; 2004 Apr; 41(3):91-6. PubMed ID: 15380734 [Abstract] [Full Text] [Related]
10. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis. Achari V, Thakur AK. J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042 [Abstract] [Full Text] [Related]
11. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE. Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [Abstract] [Full Text] [Related]
12. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey. Bruckert E, Baccara-Dinet M, Eschwege E. Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463 [Abstract] [Full Text] [Related]
16. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients. Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC. J Diabetes Complications; 2007 Apr; 21(1):7-12. PubMed ID: 17189868 [Abstract] [Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]